Icosavax Inc (ICVX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Adam K. Simpson
Employees:
30
1616 EASTLAKE AVE E, SUITE 208, SEATTLE, WA 98102
(858) 775-4523

Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial. The company was incorporated in 2017 and is headquartered in Seattle, Washington.

Data derived from most recent annual or quarterly report
Market Cap 252.473 Million Shares Outstanding39.885 Million Avg 30-day Volume 103.844 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.55
Price to Revenue47.363 Debt to Equity0.0 EBITDA-85.489 Million
Price to Book Value0.5566 Operating Margin-3323.454 Enterprise Value-96.853 Million
Current Ratio17.55 EPS Growth0 Quick Ratio16.988
1 Yr BETA 1.5024 52-week High/Low 16.45 / 2.28 Profit Margin-3255.1659
Operating Cash Flow Growth-125.0856 Altman Z-Score3.118 Free Cash Flow to Firm 0
View SEC Filings from ICVX instead.

View recent insider trading info

Icosavax Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding ICVX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ICVX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

28.7 Thousand total shares from 8 transactions

Exercise Derivative Conversion (M)

35.8 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CEARLEY CASSIA CHIEF BUSINESS OFFICER

  • Officer
 151,847 2023-03-06 7

RUSSO THOMAS JOSEPH CHIEF FINANCIAL OFFICER

  • Officer
 0 2023-02-15 5

SIMPSON ADAM K. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 0 2023-02-15 8

KANESA-THASAN NIRANJAN CHIEF MEDICAL OFFICER

  • Officer
 0 2023-02-15 5

HOLTZMAN DOUGLAS CHIEF SCIENTIFIC OFFICER

  • Officer
 0 2023-02-15 6

BEKIROGLU ELIZABETH GENERAL COUNSEL & CORP. SEC.

  • Officer
 0 2023-02-15 4

RICHARDSON CHARLES E SVP, TECHNICAL OPERATIONS

  • Officer
 165,168 2022-07-29 1

FIELDS HEIDI

  • Director
 36,571 2022-06-10 1

MCDADE MARK

  • Director
 3,566,014 2022-06-10 2

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

RA CAPITAL NEXUS FUND II, L.P.

KOLCHINSKY PETER

SHAH RAJEEV M.

  • Director
  • 10% Owner
 5,969,108 2022-06-10 1

VENEMAN ANN M

  • Director
 36,321 2022-06-10 1

WASSIL JIM

  • Director
 0 2022-06-10 2

SHIVER JOHN W.

  • Director
 20,542 2022-06-10 1

SANOFI

  • 10% Owner
 3,155,169 2021-08-02 0

ADAMS STREET PARTNERS LLC

  • FORMER 10% OWNER
 3,392,392 2021-08-02 0

QIMING U.S. HEALTHCARE FUND II, L.P.

QIMING U.S. HEALTHCARE GP II, LLC

MCDADE MARK

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
 7,041,807 2021-08-02 2

GOULD TERRY P

  • Director
 3,392,392 2021-08-02 0

CORMORANT ASSET MANAGEMENT, LP

CHEN BIHUA

CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

CORMORANT PRIVATE HEALTHCARE FUND III LP

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
 426,393 2021-08-02 0

NANODIMENSION III, L.P.

NANODIMENSION III MANAGEMENT LTD

NANODIMENSION III GP LIMITED PARTNERSHIP

NICHOLSON JONATHAN

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
 2,883,329 2021-08-02 0

YAMADA TADATAKA

  • Director
 751,326 2021-07-28 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

CEARLEY CASSIA - Officer CHIEF BUSINESS OFFICER

2023-03-08 17:45:43 -0500 2023-03-06 S 5,000 $7.75 d 151,847 direct yes -2.4602 1.3025 4.0521 4 -2.4602 2

SIMPSON ADAM K. - Director - Officer CHIEF EXECUTIVE OFFICER

2023-02-16 20:00:49 -0500 2023-02-15 M 10,677 $1.04 a 255,718 direct -7.387 -7.4972 0.0 1 -11.1356 3

BEKIROGLU ELIZABETH - Officer GENERAL COUNSEL & CORP. SEC.

2023-02-17 19:13:07 -0500 2023-02-15 A 100,000 a 100,000 direct

RUSSO THOMAS JOSEPH - Officer CHIEF FINANCIAL OFFICER

2023-02-17 19:16:50 -0500 2023-02-15 A 125,000 a 125,000 direct

CEARLEY CASSIA - Officer CHIEF BUSINESS OFFICER

2023-02-17 19:06:25 -0500 2023-02-15 A 140,000 a 140,000 direct

HOLTZMAN DOUGLAS - Officer CHIEF SCIENTIFIC OFFICER

2023-02-17 19:08:37 -0500 2023-02-15 A 90,000 a 90,000 direct

KANESA-THASAN NIRANJAN - Officer CHIEF MEDICAL OFFICER

2023-02-17 19:10:45 -0500 2023-02-15 A 110,000 a 110,000 direct

SIMPSON ADAM K. - Director - Officer CHIEF EXECUTIVE OFFICER

2023-02-17 19:03:59 -0500 2023-02-15 A 350,000 a 350,000 direct

SIMPSON ADAM K. - Director - Officer CHIEF EXECUTIVE OFFICER

2023-02-16 20:00:49 -0500 2023-02-15 M 10,677 d 417,250 direct

HOLTZMAN DOUGLAS - Officer CHIEF SCIENTIFIC OFFICER

2023-02-15 20:07:58 -0500 2023-02-14 S 3,349 $10.17 d 290,054 direct yes 2.2548 -6.9899 2.2548 2 -9.1319 4

BEKIROGLU ELIZABETH - Officer GENERAL COUNSEL & CORP. SEC.

2023-02-15 20:12:48 -0500 2023-02-13 S 5,922 $10.69 d 103,007 direct yes 2.2548 -6.9899 2.2548 2 -9.1319 4

SIMPSON ADAM K. - Director - Officer CHIEF EXECUTIVE OFFICER

2023-02-15 20:09:49 -0500 2023-02-13 S 7,506 $10.69 d 245,041 direct yes 2.2548 -6.9899 2.2548 2 -9.1319 4

HOLTZMAN DOUGLAS - Officer CHIEF SCIENTIFIC OFFICER

2023-02-15 20:07:58 -0500 2023-02-13 S 1,522 $10.69 d 293,403 direct yes 2.2548 -6.9899 2.2548 2 -9.1319 4

RUSSO THOMAS JOSEPH - Officer CHIEF FINANCIAL OFFICER

2023-02-15 20:04:39 -0500 2023-02-13 S 1,902 $10.69 d 48,686 direct yes 2.2548 -6.9899 2.2548 2 -9.1319 4

KANESA-THASAN NIRANJAN - Officer CHIEF MEDICAL OFFICER

2023-02-15 19:58:37 -0500 2023-02-13 S 1,794 $10.69 d 239,187 direct yes 2.2548 -6.9899 2.2548 2 -9.1319 4

CEARLEY CASSIA - Officer CHIEF BUSINESS OFFICER

2023-02-15 19:56:39 -0500 2023-02-13 S 1,660 $10.69 d 156,847 direct yes 2.2548 -6.9899 2.2548 2 -9.1319 4

CEARLEY CASSIA - Officer CHIEF BUSINESS OFFICER

2023-01-31 16:19:57 -0500 2023-01-30 M 25,102 $0.84 a 156,840 direct 3.2316 -2.9623 -37.1634 3.2316 2 -39.4973 27

CEARLEY CASSIA - Officer CHIEF BUSINESS OFFICER

2023-01-31 16:19:57 -0500 2023-01-30 M 25,102 d 2,511 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ICOSAVAX INC ICVX 2023-03-30 15:45:04 UTC 2.2139 2.6061 950000
ICOSAVAX INC ICVX 2023-03-30 15:15:04 UTC 2.2139 2.6061 1200000
ICOSAVAX INC ICVX 2023-03-30 14:45:03 UTC 2.2139 2.6061 1200000
ICOSAVAX INC ICVX 2023-03-30 14:15:04 UTC 2.2139 2.6061 1200000
ICOSAVAX INC ICVX 2023-03-30 13:45:04 UTC 3.1321 1.6879 1200000
ICOSAVAX INC ICVX 2023-03-30 13:15:04 UTC 3.1321 1.6879 1200000
ICOSAVAX INC ICVX 2023-03-30 12:45:04 UTC 3.1321 1.6879 1200000
ICOSAVAX INC ICVX 2023-03-29 22:15:04 UTC 3.1321 1.6879 1300000
ICOSAVAX INC ICVX 2023-03-29 21:45:05 UTC 3.1321 1.6879 1300000
ICOSAVAX INC ICVX 2023-03-29 21:15:04 UTC 3.1321 1.6879 1300000
ICOSAVAX INC ICVX 2023-03-29 20:45:06 UTC 3.1321 1.6879 1300000
ICOSAVAX INC ICVX 2023-03-29 20:15:05 UTC 3.1321 1.6879 1300000
ICOSAVAX INC ICVX 2023-03-29 19:45:05 UTC 3.1321 1.6879 1300000
ICOSAVAX INC ICVX 2023-03-29 19:15:05 UTC 3.1321 1.6879 1300000
ICOSAVAX INC ICVX 2023-03-29 18:45:06 UTC 3.1321 1.6879 1300000
ICOSAVAX INC ICVX 2023-03-29 18:15:06 UTC 3.1321 1.6879 1100000
ICOSAVAX INC ICVX 2023-03-29 17:45:06 UTC 3.1321 1.6879 1100000
ICOSAVAX INC ICVX 2023-03-29 17:15:05 UTC 3.1321 1.6879 1100000
ICOSAVAX INC ICVX 2023-03-29 16:45:05 UTC 3.1321 1.6879 1100000
ICOSAVAX INC ICVX 2023-03-29 16:15:05 UTC 3.1321 1.6879 1300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund ICVX -1100.0 shares, $-8734.0 2022-12-31 N-PORT

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments